Single-nucleotide polymorphisms (5p15.33, 15q25.1, 6p22.1, 6q27 and 7p15.3) and lung cancer survival in the European Prospective Investigation into Cancer and Nutrition (EPIC).

The single-nucleotide polymorphisms (SNPs) rs402710 (5p15.33), rs16969968 and rs8034191 (15q25.1) have been consistently identified by genome-wide association studies (GWAS) as significant predictors of lung cancer risk, while rs4324798 (6p22.1) was previously found to influence survival time in small-cell lung cancer (SCLC) patients. Using the same population of one of the original GWAS, we investigated whether the selected SNPs and 31 others (also identified in GWAS) influence survival time, assuming an additive model. The effect of each polymorphism on all cause survival was estimated in 1094 lung cancer patients, and lung cancer-specific survival in 763 patients, using Cox regression adjusted for a priori confounders and competing causes of death where appropriate. Overall, after 1558 person-years of post-diagnostic follow-up, 874 deaths occurred from all causes, including 690 from lung cancer. In the lung cancer-specific survival analysis (1102 person-years), only rs7452888 (6q27) and rs2710994 (7p15.3) modified survival, with adjusted hazard ratios of 1.19 (P = 0.009) and 1.32 (P = 0.011) respectively, taking competing risks into account. Some weak associations were identified in subgroup analysis for rs16969968 and rs8034191 (15q25.1) and rs4324798 (6p22.1) and survival in never-smokers, as well as for rs402710 in current smokers and SCLC patients. In conclusion, rs402710 (5p15.33), rs16969968 and rs8034191 (both 15q25.1) and rs4324798 (6p22.1) were found to be unrelated to survival times in this large cohort of lung cancer patients, regardless of whether the cause of death was from lung cancer or not. However, rs7452888 (6q27) was identified as a possible candidate SNP to influence lung cancer survival, while stratified analysis hinted at a possible role for rs8034191, rs16969968 (15q25.1) and rs4324798 (6p22.1) in influencing survival time in lung cancer patients who were never-smokers, based on a small sample.

[1]  B Asselain,et al.  Five-year survival for lung cancer patients managed in general hospitals. , 2011, Revue des maladies respiratoires.

[2]  R. Catarino,et al.  Prognostic Significance of Telomerase Polymorphism in Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.

[3]  J. Cunningham,et al.  A Rigorous and Comprehensive Validation: Common Genetic Variations and Lung Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[4]  T. Mok,et al.  Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis , 2009, Journal of cellular and molecular medicine.

[5]  D. Bertrand,et al.  Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence. , 2009, Addictive behaviors.

[6]  R. Houlston,et al.  The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. , 2009, Carcinogenesis.

[7]  John P. Rice,et al.  Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[8]  S. Heath,et al.  Investigation of the fine structure of European populations with applications to disease association studies , 2008, European Journal of Human Genetics.

[9]  Christopher I Amos,et al.  Common 5p15.33 and 6p21.33 variants influence lung cancer risk , 2008, Nature Genetics.

[10]  John P. Rice,et al.  A Risk Allele for Nicotine Dependence in CHRNA5 Is a Protective Allele for Cocaine Dependence , 2008, Biological Psychiatry.

[11]  Simon Heath,et al.  Lung cancer susceptibility locus at 5p15.33 , 2008, Nature Genetics.

[12]  Tatiana Foroud,et al.  Variants in nicotinic receptors and risk for nicotine dependence. , 2008, The American journal of psychiatry.

[13]  L. Bierut,et al.  Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with ‘pleasurable buzz’ during early experimentation with smoking , 2008, Addiction.

[14]  Susanna M Cramb,et al.  The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  Stephen Chanock,et al.  Population Substructure and Control Selection in Genome-Wide Association Studies , 2008, PloS one.

[16]  P. Laurent-Puig,et al.  Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma , 2008, BMC Medical Genomics.

[17]  R. Ankathil,et al.  Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India , 2008, Journal of Cancer Research and Clinical Oncology.

[18]  G. Mills,et al.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.

[19]  W. Tan,et al.  Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis , 2008, Clinical Cancer Research.

[20]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[21]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[22]  R. Ankathil,et al.  p53 Arg72Pro Polymorphism Predicts Survival Outcome in Lung Cancer Patients in Indian Population , 2008, Cancer investigation.

[23]  Hermann Brenner,et al.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. , 2007, The Lancet. Oncology.

[24]  S Beck,et al.  RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer , 2007, Oncogene.

[25]  G. O'Connor,et al.  Linkage and association with pulmonary function measures on chromosome 6q27 in the Framingham Heart Study. , 2003, Human molecular genetics.

[26]  L. Stitt,et al.  Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  L. Cardon,et al.  Population stratification and spurious allelic association , 2003, The Lancet.

[28]  F. Clavel-Chapelon,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics , 2002, Public Health Nutrition.

[29]  Chenghui Yan,et al.  [Genescan analysis of non-small cell lung cancer in the long arm of chromosome 6]. , 2002, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[30]  N. Rothman,et al.  Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. , 2000, Journal of the National Cancer Institute.

[31]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[32]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[33]  D. Schoenfeld,et al.  Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. , 1982, Biometrics.

[34]  J. Yokota,et al.  Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. , 2009, Carcinogenesis.

[35]  Bernard Asselain,et al.  Survie à cinq ans des cancers bronchiques primitifs dans les centres hospitaliers généraux , 2009 .

[36]  H. Brenner,et al.  The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study. , 2006, Journal of clinical epidemiology.

[37]  T. Bjørge,et al.  Prognosis of patients with lung cancer diagnosed in Norway, 1954-93 , 2004, Cancer Causes & Control.